What Is the Therapeutic Reference Range for Levetiracetam? Grand Round/A Case Study. 2022

Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
Department of Pharmacology and Toxicology, CHU Limoges, Limoges; and.

The Therapeutic Drug Monitoring guidelines of Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie had proposed a therapeutic reference range of 10-40 mg/L for levetiracetam in 2011. In the first version of the 2017 update, it was changed to 20-40 mg/L; however, 5 months later, in an erratum version, it was changed back to 10-40 mg/L. In this study, the authors agree with the range to 10-40 mg/L but discuss to what extent a wider interval may be proposed for certain patients.

UI MeSH Term Description Entries
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077287 Levetiracetam A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. Etiracetam,Etiracetam, (R)-,Etiracetam, R-isomer,Etiracetam, S-isomer,Keppra,UCB 6474,UCB-6474,Ucb L059,Ucb L060,Ucb-L059,Ucb-L060,alpha-ethyl-2-oxo-1-Pyrrolidineacetamide,Etiracetam, R isomer,Etiracetam, S isomer,R-isomer Etiracetam,S-isomer Etiracetam,UCB6474,UcbL060,alpha ethyl 2 oxo 1 Pyrrolidineacetamide
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug
D056164 Teaching Rounds Systematic discussions and TEACHING conducted in HOSPITALS and HEALTHCARE facilities related to patient care. Attending Rounds,Grand Rounds,Morning Report,Clinical Rounds,Morning Rounds,Clinical Round,Morning Reports,Morning Round,Report, Morning,Reports, Morning,Round, Clinical,Round, Morning,Rounds, Attending,Rounds, Clinical,Rounds, Grand,Rounds, Morning,Rounds, Teaching

Related Publications

Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
July 2023, Seizure,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
January 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
May 2022, International journal of rheumatic diseases,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
June 2022, International journal of rheumatic diseases,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
June 2022, International journal of rheumatic diseases,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
November 2017, European urology,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
January 1980, Medical teacher,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
April 1985, Ugeskrift for laeger,
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
September 2017, British journal of nursing (Mark Allen Publishing),
Sylvain Couderc, and Mondher Chouchane, and Franck Saint-Marcoux
February 2015, Clinical medicine (London, England),
Copied contents to your clipboard!